ConductScience.org, home

Gene · 9294

NIH grants1,282

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleS1PR2 papersNewest fiscal year
R01CA214461Ceramide metabolism and the regulation of PD-L1 signaling to control metastasis and resistance to immunotherapy in TNBC32025
R01HL160752Dual Functionality of Ceramide in Human Microvascular Endothelial Function32025
R01NS103988PET Sphingosine-1-Phosphate Receptor 1 (S1P1) radiotracer for inflammation response in multiple sclerosis32025
T32ES007148Training in Environmental Toxicology32025
T32HL007829Training Program in Lung Biology and Pathobiology32025
ZIAAI001206Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders32025
ZIABC011006Molecular diagnosis and outcome prediction in lymphoma32025
ZIABC011008Oncogenic mechanisms and molecular targets in lymphoma32025
ZIADC000039Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment32025
I01BX002741Role of Intestinal Bile Acid Signaling in Liver Diseases22025
I01BX003362Genetics of Cardiometabolic Diseases in the VA Population22025
IK2BX006551Unraveling the Genetic Basis and Cardiovascular Impact of Lipoprotein(a) in Diverse Populations22025
K12AR084232Building Interdisciplinary Research Careers in Women's Health22025
K12GM068524San Diego IRACDA Scholars Program22025
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant22025
P30CA044579University of Virginia Cancer Center Support Grant22025
P30DK020572Michigan Diabetes Research Center (MDRC)22025
P30DK034989Yale Liver Center22025
P30DK084567Mayo Center for Cell Signaling in Gastroenterology22025
P30DK120515San Diego Digestive Diseases Research Center22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/9294/grants?page=2